Eric L. Simpson, MD1; Emma Guttman-Yassky, MD, PhD2; David J. Margolis, MD, PhD3; et alSteven R. Feldman, MD, PhD4; Abrar Qureshi, MD5; Tissa Hata, MD6; Vera Mastey, MSc7; Wenhui Wei, PhD8; Laurent Eckert, PhD9; Jingdong Chao7; Renée J. G. Arnold, PharmD10,11; Tiffany Yu, BS10; Francis Vekeman, MA12; Mayte Suárez-Fariñas, PhD13; Abhijit Gadkari, PhD7
JAMA Dermatol. Published online July 3, 2018. doi:10.1001/jamadermatol.2018.1572Key Points
Question What is the association of atopic dermatitis severity and disease control with the patient-reported disease burden in clinical practice?